6LKD image
Deposition Date 2019-12-19
Release Date 2020-12-23
Last Version Date 2023-11-22
Entry Detail
PDB ID:
6LKD
Title:
in meso full-length rat KMO in complex with a pyrazoyl benzoic acid inhibitor
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.22
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Kynurenine 3-monooxygenase
Gene (Uniprot):Kmo
Chain IDs:A, B
Chain Length:495
Number of Molecules:2
Biological Source:Rattus norvegicus
Primary Citation
Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition.
Commun Biol 4 159 159 (2021)
PMID: 33542467 DOI: 10.1038/s42003-021-01666-5

Abstact

The structural mechanisms of single-pass transmembrane enzymes remain elusive. Kynurenine 3-monooxygenase (KMO) is a mitochondrial protein involved in the eukaryotic tryptophan catabolic pathway and is linked to various diseases. Here, we report the mammalian full-length structure of KMO in its membrane-embedded form, complexed with compound 3 (identified internally) and compound 4 (identified via DNA-encoded chemical library screening) at 3.0 Å resolution. Despite predictions suggesting that KMO has two transmembrane domains, we show that KMO is actually a single-pass transmembrane protein, with the other transmembrane domain lying laterally along the membrane, where it forms part of the ligand-binding pocket. Further exploration of compound 3 led to identification of the brain-penetrant compound, 5. We show that KMO is dimeric, and that mutations at the dimeric interface abolish its activity. These results will provide insight for the drug discovery of additional blood-brain-barrier molecules, and help illuminate the complex biology behind single-pass transmembrane enzymes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures